4//SEC Filing
Karam Sammy 4
Accession 0001415889-22-001739
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:16 PM ET
Size
5.4 KB
Accession
0001415889-22-001739
Insider Transaction Report
Form 4
Karam Sammy
Senior Vice President
Transactions
- Award
Option (right to buy)
2022-02-18+59,708→ 59,708 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (59,708 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,902 on February 18, 2023, 19,903 on February 18, 2024, and 19,903 on February 18, 2025.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001766718
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:16 PM ET
- Size
- 5.4 KB